News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
501,832 Results
Type
Article (11195)
Company Profile (190)
Press Release (490443)
Multimedia
Podcasts (7)
Webinars (6)
Section
Business (171496)
Career Advice (364)
Deals (26349)
Drug Delivery (14)
Drug Development (54541)
Employer Resources (19)
FDA (10046)
Job Trends (9103)
News (244943)
Policy (18729)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (6)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (682)
Accelerated approval (27)
ADA (22)
Adcomms (1)
Allergies (100)
Alliances (34188)
ALS (136)
Alzheimer's disease (1049)
Antibody-drug conjugate (ADC) (309)
Approvals (10725)
Artificial intelligence (378)
ASCO (167)
Autoimmune disease (238)
Automation (32)
Bankruptcy (272)
Belgium (3)
Best Places to Work (7132)
BIO (38)
Biologics (14)
BIOSECURE Act (2)
Biosimilars (119)
BioSpace Insights (21)
Biotechnology (121)
Bispecific (3)
Bladder cancer (140)
Brain cancer (36)
Breast cancer (531)
Cancer (3985)
Cardiovascular disease (243)
Career advice (303)
Career pathing (6)
CAR-T (193)
CDC (2)
CDMO (33)
Celiac Disease (1)
Cell therapy (533)
Cervical cancer (36)
Clinical research (49483)
Collaboration (1375)
Commercialization (6)
Company closure (3)
Compensation (1559)
Complete response letters (35)
COVID-19 (905)
CRISPR (71)
C-suite (874)
Cystic fibrosis (94)
Data (6181)
Denatured (4)
Depression (111)
Dermatology (80)
Diabetes (382)
Diagnostics (4358)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (181)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (184)
Earnings (74597)
Editorial (3)
Employer branding (3)
Employer resources (18)
Events (90710)
Executive appointments (762)
FDA (12918)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (1038)
Gene editing (143)
Generative AI (14)
Gene therapy (372)
GLP-1 (323)
Government (1108)
Grass and pollen (2)
Guidances (289)
Healthcare (9897)
Hematology (99)
HIV (61)
Huntington's disease (32)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (70)
Immunology and inflammation (130)
Immuno-oncology (67)
Indications (170)
Infectious disease (1104)
Inflammatory bowel disease (134)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (268)
Interviews (47)
IPO (12603)
IRA (2)
Job creations (2254)
Job search strategy (286)
JPM (4)
Kidney cancer (17)
Kidney disease (48)
Labor market (44)
Layoffs (167)
Leadership (1)
Legal (5571)
Licensing (24)
Liver cancer (48)
Longevity (21)
Lung cancer (576)
Lung diease (9)
Lymphoma (266)
Machine learning (31)
Management (3)
Manufacturing (645)
Marketing (9)
MASH (124)
Medical affairs (2)
Medical device (8992)
Medtech (9160)
Mergers & acquisitions (14838)
Metabolic disorders (783)
mRNA (90)
Multiple sclerosis (112)
NASH (4)
Neurodegenerative disease (250)
Neuropsychiatric disorders (41)
Neuroscience (2018)
NextGen: Class of 2026 (3405)
Non-profit (1122)
Now hiring (34)
Obesity (252)
Opinion (22)
Ovarian cancer (173)
Pain (185)
Pancreatic cancer (217)
Parkinson's disease (219)
Partnered (12)
Patents (512)
Patient advocacy (1)
Patient recruitment (553)
Patient selection (14)
Peanut (34)
People (43260)
Peptides (5)
Pharmaceutical (35)
Pharmacy benefit managers (10)
Phase 1 (16017)
Phase 2 (22127)
Phase 3 (14962)
Pipeline (8170)
Policy (31)
Postmarket research (1599)
Preclinical (6815)
Press Release (34)
Prostate cancer (203)
Psychedelics (11)
Radiopharmaceuticals (209)
Rare diseases (646)
Real estate (3376)
Recruiting (10)
Regenerative medicine (7)
Regulatory (15512)
Reports (31)
Research institute (733)
Resumes & cover letters (48)
Rett syndrome (45)
RNA editing (9)
RSV (52)
Schizophrenia (109)
Series A (181)
Series B (134)
Service/supplier (6)
Sickle cell disease (69)
Special edition (6)
Spinal muscular atrophy (98)
Sponsored (5)
Startups (2216)
State (1)
Stomach cancer (5)
Substance use disorders (16)
Supply chain (56)
Tariffs (8)
The Weekly (3)
Vaccines (379)
Venture capital (27)
Weight loss (86)
Wet AMD (1)
Women's health (93)
Worklife (3)
Date
Today (8)
Last 7 days (365)
Last 30 days (1413)
Last 365 days (19707)
2026 (14799)
2025 (19873)
2024 (23654)
2023 (27278)
2022 (35442)
2021 (38182)
2020 (34577)
2019 (24718)
2018 (18529)
2017 (19688)
2016 (18827)
2015 (24992)
2014 (22267)
2013 (18638)
2012 (20788)
2011 (20931)
2010 (20746)
Location
Africa (262)
Alabama (81)
Alaska (2)
Arizona (315)
Arkansas (11)
Asia (18620)
Australia (2295)
California (12628)
Canada (3316)
China (579)
Colorado (519)
Connecticut (444)
Delaware (222)
Europe (27366)
Florida (1899)
Georgia (400)
Hawaii (3)
Idaho (46)
Illinois (773)
India (55)
Indiana (343)
Iowa (18)
Japan (450)
Kansas (105)
Kentucky (36)
Louisiana (27)
Maine (28)
Maryland (1271)
Massachusetts (9112)
Michigan (322)
Minnesota (587)
Mississippi (5)
Missouri (86)
Montana (20)
Nebraska (13)
Nevada (127)
New Hampshire (61)
New Jersey (2807)
New Mexico (13)
New York (2983)
North Carolina (1353)
North Dakota (6)
Northern California (6333)
Ohio (309)
Oklahoma (14)
Oregon (21)
Pennsylvania (2348)
Puerto Rico (27)
Rhode Island (35)
South America (440)
South Carolina (81)
South Dakota (1)
Southern California (5260)
Tennessee (133)
Texas (2072)
United States (41741)
Utah (381)
Vermont (1)
Virginia (172)
Washington D.C. (46)
Washington State (979)
West Virginia (3)
Wisconsin (83)
Wyoming (1)
501,832 Results for "tesaro inc waltham massachusetts".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
$40M in tax incentives expected to generate 1,600+ life sciences jobs in Massachusetts
Of the 38 companies receiving incentives, 31 will expand outside of Boston and Cambridge. Still, Boston and Cambridge are each expected to gain over 200 jobs. Tax incentive award recipients include AstraZeneca, Bristol Myers Squibb and Insulet.
September 30, 2026
·
1 min read
·
Angela Gabriel
Job Trends
Massachusetts biopharma jobs, including R&D positions, fell in 2025: Report
After barely growing in 2024, biopharma employment in Massachusetts dropped 3.1% last year. R&D jobs dipped even more, by 3.9%. Biomanufacturing, however, went up.
August 25, 2026
·
3 min read
·
Angela Gabriel
Press Releases
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts
August 25, 2025
·
3 min read
Legal
UPDATE: GSK’s Tesaro Sues AnaptysBio Over Current Jemperli Contract; Anaptys Countersues
After GSK subsidiary Tesaro filed a lawsuit Thursday claiming that AnaptysBio breached “certain requirements” under their 2014 license agreement involving GSK’s Jemperli, Anaptys responded Friday morning.
November 21, 2025
·
3 min read
·
Tristan Manalac
Job Trends
17 companies expected to create 400+ Massachusetts jobs add under 50
Seventeen life sciences businesses awarded Massachusetts tax incentives to add and retain 426 combined jobs hit 10% of that target as of Dec. 31. Three companies, including Novartis, had reported layoffs either last year or this year.
June 1, 2026
·
4 min read
·
Angela Gabriel
Press Releases
Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts
October 1, 2026
·
7 min read
Job Trends
Massachusetts’ life sciences employment dipped last year following 14 years of growth: report
Massachusetts’ life sciences jobs declined 1% in 2025, according to a new MassBioEd report. However, the report is projecting industry employment will increase 9.7% by 2030. It also noted reskilling needs for some roles, including scientists.
June 4, 2026
·
2 min read
·
Angela Gabriel
Press Releases
CereVasc Opens New Massachusetts Facility in Preparation for eShunt® System Commercialization
July 30, 2026
·
3 min read
Job Trends
$17M in Tax Incentives Will Add 800 Life Sciences Jobs This Year in Massachusetts
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
October 24, 2025
·
2 min read
·
Angela Gabriel
Business
Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts
Cambrex announced that Snapdragon Chemistry has completed the second phase of its 51,000 square foot expansion in Waltham, Massachusetts.
May 16, 2023
·
2 min read
1 of 50,184
Next
